Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing’s Sarcoma and Prostate Carcinoma

  • Maria J. Camões ,

    Contributed equally to this work with: Maria J. Camões, Paula Paulo

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

  • Paula Paulo ,

    Contributed equally to this work with: Maria J. Camões, Paula Paulo

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

  • Franclim R. Ribeiro,

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

  • João D. Barros-Silva,

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

  • Mafalda Almeida,

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal

  • Vera L. Costa,

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal

  • Nuno Cerveira,

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

  • Rolf I. Skotheim,

    Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  • Ragnhild A. Lothe,

    Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  • Rui Henrique,

    Affiliations Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal, Department of Pathology, Portuguese Oncology Institute-Porto, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal

  • Carmen Jerónimo,

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal

  • Manuel R. Teixeira

    manuel.teixeira@ipoporto.min-saude.pt

    Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.